The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 1 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Opinion
Neuralink's clinical-first strategy leads to grindingly slow progress, says Thomas Reardon
“Whereas if you go just to the clinical population first, which is sort of where Neuralink is going with their work, it's just grindingly slow progress.”
Thomas Reardon Sep 17, 2019 ▶ 23:55 Fireside Chat: Thomas Reardon, Founder & CEO, CTRL-Labs (FirstMark's Data Driven NYC)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 400 conversations transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.